Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Glaxosmithkline (GSK) Share News

121314151617181920

Sareum served notice on commercial licence for cancer treatment

31st Dec 2024 10:50

(Alliance News) - Sareum Holdings PLC on Tuesday said a biopharma company in the US has served notice to terminate a development & commercialisation licence for Sareum's SRA737 clinical-stage cancer treatment. Read More

GSK reports mixed findings from ovarian cancer phase III study

20th Dec 2024 08:58

(Alliance News) - GSK PLC on Friday said a trial of two ovarian cancer treatments met its primary endpoint but did not meet a key secondary target. Read More

LONDON BRIEFING: Stocks down as UK retail sales miss forecasts

20th Dec 2024 07:52

(Alliance News) - Stocks were called lower on Friday ahead of the US Fed's preferred inflation gauge, the personal consumption expenditures reading, this afternoon. Read More

LONDON MARKET MIDDAY: Stocks red as UK consumer confidence erodes

16th Dec 2024 12:04

(Alliance News) - Stock prices in London were down at midday on Monday, while in corporate news Videndum shares fell after its trading update disappointed. Read More

GSK receives three positive regulatory updates on cancer products

16th Dec 2024 09:34

(Alliance News) - GSK PLC on Monday reported a triple dose of good news with positive regulatory updates on two leading cancer drugs. Read More

LONDON BROKER RATINGS: RBC raises Hikma; JPMorgan cuts Schroders

10th Dec 2024 10:01

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

IN BRIEF: GSK highlights positive Blenrep data from Dreamm-7 trial

9th Dec 2024 19:42

GSK PLC - London-based pharmaceuticals firm - Says Dreamm-7 trial shows sustained overall survival benefit for Blenrep, the brand name of belantamab mafodotin, combination versus a daratumumab combination. The data build on findings from Dreamm-7 and Dreamm-8 and supports the potential for Blenrep combinations to become standard of care. Blenrep shows significant overall survival benefit, reducing the risk of death by 42% in multiple myeloma at or after first relapse, company says. Read More

GSK's Nucala and Blenrep receive regulatory boost in US and China

9th Dec 2024 08:47

(Alliance News) - GSK PLC on Monday received a double-dose of good news with its Nucala and Blenrep products receiving positive indications from industry regulators. Read More

LONDON BRIEFING: boohoo gets ISS backing amid Frasers Group spat

9th Dec 2024 07:51

(Alliance News) - London's FTSE 100 is called higher, while stocks in Hong Kong perked up amid after a slow start amid fresh hope for the Chinese economy. Read More

GSK expands Chinese shingles vaccine collaboration with Zhifei

5th Dec 2024 09:19

(Alliance News) - GSK PLC on Thursday said it has expanded its shingles vaccine collaboration with Chongqing Zhifei Biological Products Ltd in China, including an extended term length. Read More

Vodafone taps former GSK CFO Simon Dingemans as non-executive director

4th Dec 2024 09:26

(Alliance News) - Vodafone Group PLC on Wednesday said the former chief financial officer of drugs maker GSK PLC will join its board as a non-executive director. Read More

LONDON BROKER RATINGS: Deutsche Bank raises AB Foods and Burberry

2nd Dec 2024 09:34

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and on Friday: Read More

TOP NEWS: GSK hails EU Approval of Menveo vaccine in new format

27th Nov 2024 09:23

(Alliance News) - GSK PLC on Wednesday said its meningitis vaccine, Menveo, has received approval from the European Commission in a new single-vial, fully liquid presentation. Read More

GSK's Blenrep combinations accepted for review by US FDA

25th Nov 2024 08:54

(Alliance News) - GSK PLC said on Monday that the US Food & Drug Administration accepted a biologics license application for its Blenrep combinations for the treatment of relapsed and refractory multiple myeloma, both forms of bone marrow cancer. Read More

TOP NEWS: GSK's Arexvy RSV vaccine approved in Japan for adults 50-59

22nd Nov 2024 08:40

(Alliance News) - GSK PLC said on Friday that Japan's Ministry of Health, Labour & Welfare has approved the expansion of its Arexvy respiratory syncytial virus vaccine to include adults aged 50 to 59 who are at increased risk of severe RSV. Read More

LONDON BRIEFING: GSK approval; Games Workshop trades ahead of forecast

22nd Nov 2024 07:52

(Alliance News) - London's FTSE 100 is called to open higher on Friday, while the pound and euro struggled ahead of a series key purchasing managers' index readings. Read More

GSK hails positive results for linerixibat in treating relentless itch

19th Nov 2024 09:24

(Alliance News) - GSK PLC on Tuesday said that its investigational targeted inhibitor linerixibat demonstrated sound results for a treatment of relentless itch. Read More

LONDON BROKER RATINGS: HSBC says 'buy' recruiters SThree and Hays

18th Nov 2024 09:36

(Alliance News) - The following London-listed shares received analyst recommendations on Monday morning and Friday: Read More

LONDON BRIEFING: Elementis says CEO Waterman to step down next year

18th Nov 2024 08:00

(Alliance News) - The FTSE 100 was called to open lower on Monday, ahead of trade balance data from the eurozone and comments from Bank of England Governor Andrew Bailey. Read More

LONDON MARKET CLOSE: Stocks struggle as Powell signals slower Fed cuts

15th Nov 2024 16:51

(Alliance News) - Stock prices in London closed lower, while equities in New York opened in the red after Federal Reserve Chair Jerome Powell dashed rate cut hopes overnight. Read More

121314151617181920
FTSE 100 Latest
Value10,323.75
Change128.38